Fierce Biotech June 10, 2024
Helen Floersh

Against a backdrop of low-volume but growing concerns about bird flu, the National Institutes of Health’s (NIH’s) infectious disease arm has laid out its plans to study the virus that causes the illness.

In a document (PDF) released publicly June 5, the NIH’s National Institute of Allergy and Infectious Diseases (NIAID) explained that it planned to track the H5N1 virus’s evolution, study its clinical course and come up with prevention, diagnostic and treatment strategies.

The agenda “hits on all the right issues,” Nigel Sizer, Ph.D., executive director of the Preventing Pandemics at the Source initiative, told Fierce Biotech Research in an email.

The new effort builds upon existing work, Sizer pointed out. Even before the virus was discovered in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID, Survey / Study, Trends
Growing gulf in US life expectancy deepened by COVID-19 pandemic
Stick to the Science
Understanding the Growing Impact of Obesity in the United States
Wearable electrical nerve stimulation device eases long COVID pain and fatigue, say researchers
Transforming public health: a physician’s innovative approach [PODCAST]

Share This Article